Melvin Hayes

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Gregory Tourangeau, as attorney-in-fact for Melvin Hayes
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Melvin Hayes:

Company Role Class Num Shares Value Price $ Report Date Ownership
Fulcrum Therapeutics, Inc. Chief Operating Officer Stock Option (right to buy) 115,000 26 Apr 2023 Direct
Fulcrum Therapeutics, Inc. Chief Operating Officer No securities are beneficially owned 0 09 Aug 2022 Direct

Insider Reports Filed by Melvin Hayes

Symbol Company Period Transactions Value $ Form Type Role Filing Time
FULC Fulcrum Therapeutics, Inc. 26 Apr 2023 1 $0 4 Chief Operating Officer 28 Apr 2023, 16:17
FULC Fulcrum Therapeutics, Inc. 09 Feb 2023 1 $0 4 Chief Operating Officer 13 Feb 2023, 15:15
FULC Fulcrum Therapeutics, Inc. 09 Aug 2022 1 $0 4 Chief Operating Officer 11 Aug 2022, 16:15
FULC Fulcrum Therapeutics, Inc. 09 Aug 2022 0 $0 3 Chief Operating Officer 11 Aug 2022, 16:10